Cryptococcus infection:

An emerging global threat to human health


yearly cases of infection among only HIV+ patients with significant mortality rates (41-61%).


of all HIV-related deaths are linked to cryptococcal infections.


increase in Europe & North America cases since 2009.


fungal pathogen of concern (World Health Organization) with emerging drug resistance.

"Antifungals are usually broad spectrum – that’s a problem driving the resistance crisis in Cryptococcus infections. NeoPeptix is NuvoBio’s peptide-based narrow spectrum solution."

Curious About NeoPeptix?
Reach Out to Us for a Chat and Discover More!